Cinctive Capital Management »

BioMarin Pharmaceutical shares owned by Cinctive Capital Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Cinctive Capital Management from 13F filings

Historical chart of Cinctive Capital Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Cinctive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Cinctive Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6M 42k 87.34

More positions owned by Cinctive Capital Management

General Electric Com New Put Option (GE)
Ishares Tr Russell 2000 Etf Call Option (IWM)
AES Corporation (AES)
Impinj (PI)
Nextera Energy (NEE)
Vistra Energy (VST)
Starbucks Corporation Call Option (SBUX)
Humana Call Option (HUM)
Array Technologies Com Shs (ARRY)
Snowflake Cl A (SNOW)
Antero Midstream Corp antero midstream (AM)
Amazon (AMZN)
Jefferies Finl Group (JEF)
salesforce (CRM)
Western Digital (WDC)

View all positions for Cinctive Capital Management

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical